XLO vs ZBH · rev $31.3M vs P/E 23, rev $4.26B
Xilio Development Inc (XLO) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Xilio Development Inc (XLO) is a biotechnology company listed on NASDAQ.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported XLO revenue for 2026-06-30 was $31.3M. Net income was -$15.9M. XLO currently screens at market cap $55.3M.
Latest reported ZBH revenue for 2026-06-30 was $4.26B. Net income was $436.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
XLO currently screens at market cap $55.3M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the XLO and ZBH stock pages for the full models.
Not investment advice.